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Complexity 
 
 
 
Filamentous bacteriophages were engineered to express foreign genes with the ultimate 
purpose of displaying transmission control anti-malarial peptides as in phage display. It was 
hypothesized that expression of foreign genes would be possible using the phage’s promoters. 
This hypothesis was tested by assuming that promoters for the phage major coat protein (MCP) 
gene would also promote the expression of any foreign gene inserted downstream of the MCP 
gene. As proof of principle, the bacteriophages Pf3, Pf1, and M13 were engineered in this way to 
successfully synthesize Enhanced Green Fluorescent Protein (EGFP). Type 88 phage display on 
the EGFP recombinant Pf3 was attempted by fusing a second copy of its MCP gene to the 
existing EGFP gene. This resulted in a phage display Pf3 replacement vector which was then 
used to construct a phage for displaying an anti-malarial peptide.  
 
 
 1. Introduction 
 
 
 
1.1 Bacteriophages 
There are an estimated 1031 different bacteriophages (phages) on earth (Breitbart, 2005).  
Phages are the largest group of biological entities found in the world (Ackermann, 2003).  Even 
though phages outnumber all other entities on earth, relatively little is known about most of 
them.  There is a tremendous potential for scientific advancement through the use of phages in 
several fields including biomedical research and nanotechnology (Rakonjac, 2011; Dang, 2011; 
Chandler, 2011). 
As Ackermann cited, there are thirteen different families of phages (Table 1, Figure 1, 
Ackermann, 2003).   
      1 
 
 Table 1: Bacteriophages and their distinguishing features* 
 
Family Name Distinguishing Features 
Microviridae Polyhedral shape; Single-stranded, circular DNA 
Myoviridae Contractile tail; Double-stranded, linear DNA 
Siphoviridae Long, non-contractile tail; Double-stranded linear DNA 
Podoviridae Short, non-contractile tail; Double-stranded linear DNA 
Corticoviridae Complex capsid; lipids; Double-stranded, circular DNA 
Tectiviridae Double-stranded, linear DNA; Internal lipoprotein vesicle 
Lipothrixviridae Envelope; lipids; Double-stranded, linear DNA 
Plasmaviridae Envelope; Lipids; No capsid; Double-stranded, circular DNA 
Rudiviridae Helical rods; Double-stranded, lineasr DNA 
Fuselloviridae Spindle-shaped; no capsid; Double-stranded, circular DNA 
Inoviridae Rods or filaments; Single-stranded, circular DNA 
Leviviridae Single-stranded, linear RNA 
Cystoviridae Double-stranded, linear RNA 
* Ackermann, 2003 
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Figure 1: Morphologies of bacteriophages.  (Reprinted with permission from Ackermann, H.W. 
(2003). Bacteriophage observations and evolution. Research in Microbiology, 154, 245-251. 
Copyright 2003 Elsevier). 
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 Phages in each family have different morphological and genomic characteristics.  For 
example, all Siphoviridae have long non-contractile tails and a double-stranded DNA genome, 
while the Leviviridae lack tails, and have ssRNA genomes surrounded by a simple capsid.  Phage 
genomes may be either DNA or RNA and may be single stranded or double stranded. All phages 
use the replication system of their host cell; some completely take over the host and eventually 
cause cell lysis while others are able to replicate without severely disrupting the host cell.  Some 
phages are able to integrate into the host bacterial cell genome where they may propagate or 
remain dormant until triggered by some environmental factor. This study will focus on the 
Inoviridae, which are filamentous phages with a single-stranded DNA genome.  
 The genomes of all phages from the family Inoviridae are composed of circular, single-
stranded DNA which, once inside the host cell, is converted into double stranded DNA, known 
as the replicative form, and replicates by a rolling circle mechanism (Gilbert and Dressler, 1968). 
The genera Plectrovirus and Inovirus include filamentous phages, thusly named for their long, 
rod like shape. The Inoviridae lack genes encoding proteins that lyse their host bacteria.  Because 
they replicate without killing their host, filamentous phages may be produced and extruded by 
the host cell indefinitely (Paschke, 2006).  Some filamentous phages integrate into the host 
genome and become temperate while others not (Rakonjac, 2011).  The majority of hosts for 
filamentous phages are Gram negative bacteria but there are two known filamentous phages with 
Gram positive bacterial hosts (Rakonjac, 2011).  Filamentous phage hosts display a pilus, which 
is how the phage initially interacts with the bacteria (Iannolo, 1995; Russel, 1997).  In 
filamentous phage M13, 1) the N-terminal domain of protein III at the end of the phage attaches 
to the F pilus, 2) the pilus retracts to the bacterial cell drawing the phage in, 3) it interacts with a 
secondary receptor and then 4) it is allowed to enter the cell with the N-terminal domain of 
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 protein III entering first (Smith, 1997).  As the phage enters the cell, the coat proteins encasing 
the phage genome are removed (Russel, 1997).  Upon completion of phage genome replication, a 
copy of the DNA is encased by the phage’s coat proteins as it passes through the cell membrane 
exiting the cell; the first portion of the phage to emerge from the cell is the packaging signal end 
(Russel, 1997). 
 The best studied group of filamentous phages is the Ff group which includes M13, fd and 
f1; the following discussion of genome contents and phage structure is based on this group 
(Russel, 1997; Rakonjac 2011).  The DNA of a filamentous phage codes for the production of 
ten to eleven proteins (Figure 2).  
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Figure 2:  Genome map of model filamentous phage M13. Each gene is indicated by the red 
circular arrows and the gene number is indicated in roman numerals.  Genome map created using 
CGView. 
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 Of these, 5 are assembled into the phage coat.  The major coat protein, encoded by gene 
VIII, covers the body of the phage while the ends are covered by minor coat proteins, encoded 
by genes III, VI, VII, and IX (Rakonjac, 2011).  Genes II, V, and X, are responsible for DNA 
synthesis while genes I and IV are responsible for phage assembly (Russel, 1997).  Filamentous 
phages are structured such that their genomes are encapsidated in proteins.  There are 
approximately 2700 copies of the major coat protein surrounding the single-stranded phage DNA 
(Wang, 2010).  Approximately 5 copies of each of the minor coat proteins can be found on the 
phage coat; 5 copies of protein IV and 5 copies of protein III on one end and 5 copies of protein 
VII and 5 copies of protein IX on the other end (Wang, 2010).  Proteins VII and IX are essential 
for phage particle assembly while proteins III and IV are necessary for stability and infectivity.  
More specifically, protein III is responsible for interaction with the bacterial host F pilus as well 
as removing the phage coat and allowing the genome access to the host cell’s cytoplasm (Russel, 
1997).  There are several ways in which the phage may exit its host cell.  In some filamentous 
phages, protein IV, which is homologous to host secretins, may form a complex in the membrane 
to create a gated channel for the phage to exit through (Iannolo, 1995).  Alternatively, as in 
phage CTXФ, the phage may use the host cell secretins but phage production is very low in these 
systems, indicating a lower efficiency in using host secretins (Rakonjac, 2011). 
1.2 Phage Display 
Smith first proposed creating a “fusion phage” in which a foreign peptide was fused to 
protein III of filamentous phage f1 (Smith, 1985). The widely used technology of phage display 
arose from this.  In phage display, a foreign peptide is fused to a phage coat protein, usually 
protein III or VIII and a spacer, or hinge, may be used to distance the foreign peptide from the 
phage (Smith, 1997; Kim, 2004).  While proteins III and VIII are the most frequently used, any 
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 phage coat protein may be used to link a foreign peptide for phage display.  The peptides are 
situated on the N-terminal side of either protein III or VIII so that they are exposed on the 
surface of the phage as opposed to being internalized (Smith, 1997).  There are 20 amino acids of 
protein VIII naturally exposed on the surface of the phage, which provide a large target for 
attaching a foreign peptide (Kim, 2004).  The expressed foreign peptide generally acts as if it 
were not attached to the phage coat because of its accessibility to solvent and any spacers or 
hinges that are used (Smith, 1997).   
There are six popular models of phage display that are theoretically possible: Type 3, 
Type 33, Type 3+3, Type 8, Type 88, and Type 8+8 as shown in Figure 3 (Smith, 1997).   
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Figure 3:  Types of phage display.  The black boxes in the genome indicate the location of gene 8 
or derivatives of gene 8 while the white boxes indicate the location of gene 3 or gene 3 
derivatives.  The grayed box indicates the location of the foreign peptide in each construct.  The 
grayed spheres indicate the location of the foreign gene on the phage coat. (Reprinted with 
permission from Smith, G.P. and Petrenko, V.A. (1997). Phage Display. Chemistry Review, 97, 
391-410.  Copyright 1997 American Chemical Society). 
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 In Type 3 and Type 8 phage display, the DNA sequence for the foreign peptide is directly 
fused to the one and only copy of the given coat protein gene, protein III or protein VIII 
respectively, and thereby should be expressed on every copy of that coat protein on the phage 
(Smith, 1997).  These two types of phage display are rarely viable because the foreign peptide 
disrupts the ability of the coat proteins to align correctly around the phage DNA. Only small 
peptides of fewer than 8 amino acids may be used in this type of phage display (Smith, 1997).  In 
Type 33 and Type 88 phage display, a second copy of the given coat protein gene is inserted into 
the genome of the phage and that second copy is fused to the foreign peptide (Smith, 1997).  In 
this type of system the phage itself produces both the wild type coat protein as well as the fusion 
coat protein. Upon phage assembly a few of the fusion coat proteins may be incorporated on to 
the phage coat without disrupting the coat protein alignment and thereby producing viable 
phages; this dual-expression system allows for the use of large foreign peptides (Smith, 1997).  
Type 3+3 and Type 8+8 systems require two genetic elements; the phage contains the wild type 
coat protein, this entity is usually called the “helper phage”.  An accompanying plasmid contains 
the coding sequence for the phage’s coat protein gene fused to the foreign peptide gene, this is 
usually called the “phagemid” (Smith, 1997).  Within Type 3+3 and Type 8+8 the same principle 
of having the foreign peptide on only a few copies of the phage coat applies and creates a viable 
phage.  The requirement of two genetic elements increases the difficulty of engineering a Type 
88 or Type 33 phage display system but is the most commonly used type of phage display 
(Smith, 1997).  In order to use type 8+8 or type 3+3 phage display, a plasmid must be 
characterized for the host bacteria.  In types 33 and 3+3 it is common to only have one or fewer 
copies of the foreign peptide displayed (or expressed) on each phage, since gene III is a minor 
protein and present in just a few copies per phage.  The number of foreign peptides exposed in 
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 types 88 and 8+8 depends upon the size of the foreign peptide (Wang, 2010).  Smaller peptides 
tend to be expressed in higher numbers because the space on the phage coat is limited and higher 
numbers of small peptides are able to fit together.   
There are a wide range of applications for phage display that use the same concept of 
fusing a foreign peptide to a phage coat protein to explore the molecular interactions of the 
foreign peptide.  These applications include the detection of monoclonal antibodies (Wang, 
2010) and the study of molecular interactions (Lanzillotti, 2007).  To study molecular 
interactions, the peptide on the phage coat mimics a ligand to probe receptors (Lanzillotti, 2007). 
Additionally, phage display is the basis for the creation of peptide and protein libraries (Wang, 
2010) to enable the screening of a large number of molecules in an interaction assay.  Host-
parasite interactions may also be discovered and characterized through phage display 
(Lanzillotti, 2007).  The biggest advantage of phage display is the ability to recover the phages 
and identify the peptide that is attached (Wang, 2010).  Alternatively, a sample may be probed 
with free peptides which can not be recovered in large quantities.   
Our specific interest is to use phage display to study ligand-receptor interactions of a 
host-pathogen system.  One of the most extensively researched host-pathogen interactions is of 
the malaria parasite, Plasmodium, with its mosquito host.  Within the mosquito host, the 
parasite’s lifecycle can be interrupted by blocking the molecular interaction between the parasite 
and the mosquito tissue. Phage infecting bacteria residing in the mosquito gut may provide an 
opportunity to use phage display as a novel anti-malarial approach.  The following sections will 
describe the disease and preliminary work to create a phage display system to block transmission 
of Plasmodium. 
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 1.3 Malaria: The Disease and the Parasite 
Malaria dates back over four thousand years in recorded history and has had a large 
influence on shaping human history and populations (CDC, 2010).  Each year approximately 
1500 cases of malaria are diagnosed in the United States; most of these cases occur in travelers 
and immigrants from areas where malaria is present (CDC, 2010).  There is also the possibility 
of native mosquitoes becoming infected by travelers from malaria endemic regions and then 
transmitting the infection to residents (CDC, 2010).  Even though malaria has been officially 
eradicated in the United States, the three main mosquito vectors, Anopheles quadrimaculatus, 
Anopheles freeborni, and Anopheles albimans, are still present meaning there is still a risk of a 
malaria outbreak (CDC, 2010).  While malaria does not pose a significant and immediate health 
risk in the United States, it is still a large problem in many countries.   
Approximately half of the world’s population lives in areas which put them at risk to 
contract malaria (CDC, 2010).  Over a million people are killed by the disease worldwide each 
year (CDC, 2010).  Malaria is the second most deadly disease in Africa; second only to 
HIV/AIDS (CDC, 2010).  Sub-Saharan Africa is most strongly affected by the disease; in the 
year 2008, there were approximately 200 million cases of malaria worldwide with approximately 
one million people dying of the disease in sub-Saharan Africa, the majority of them children 
(CDC, 2010). 
Malaria is caused by parasites of the genus Plasmodium.  There are over one hundred 
known species of Plasmodium. These species are thought to be host specific, and can infect 
assorted animals ranging from reptiles to birds to mammals including humans (CDC, 2010).  Of 
the numerous species of Plasmodium, only five are known to infect humans; those are 
Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, and 
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 Plasmodium knowlesi (CDC, 2010).  Of the human malarias, P. falciparum is the most deadly, 
killing approximately one million people each year; however, P. vivax is the most prevalent 
(CDC, 2010). 
The lifecycle of Plasmodium entails infection of an invertebrate as well as a vertebrate 
host (Figure 4; CDC, 2010).   
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Figure 4:  The lifecycle of the malaria parasite.  Here the lifecycle of the parasite can be seen in 
both the invertebrate host, the mosquito, and the vertebrate host, in this case, a human.  The 
development from ookinete to oocyst can be hindered by the SM1 peptide.  The peptide blocks 
the ookinete interaction with a receptor in the mosquito midgut essential for its differentiation 
into an oocyst.  "Life cycle of the malaria parasite" from Epidemiology of Infectious Diseases. 
Available at: http://ocw.jhsph.edu. Copyright © Johns Hopkins Bloomberg School of Public 
Health. Creative Commons BY-NC-SA.
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Female mosquitoes serve as the invertebrate host of Plasmodium (CDC, 2010).   Even 
though there are approximately four hundred and thirty Anopheles species, only thirty to forty 
species are able to transmit mammalian malaria parasites (CDC, 2010). Plasmodium 
gametocytes are found in the bloodstream of infected mammalian hosts; the gametocytes are 
transferred to Anopheline mosquitoes during a blood meal which is needed for egg production 
(CDC, 2010).  In the mosquito mid-gut the two forms of gametocytes, macro- and 
microgametocytes, fuse to form the zygote, which develops into the ookinete.  The ookinete 
traverses the midgut epithelium forming the oocysts.  Upon maturation, the oocyst ruptures 
thereby releasing sporozoites which then migrate to the salivary glands (CDC, 2010).  These 
sporozoites are then injected with the mosquito’s saliva into the next human blood meal host 
(CDC, 2010).  Once inside the newly infected human host, Plasmodium travels to the liver where 
it develops into a schizont.  The schizont ruptures, allowing between thirty thousand and forty 
thousand merozoites to enter the blood stream and parasitize the red blood cells of the human 
host.  These merozoites develop into gametocytes, perpetuating the life cycle of the parasite 
(CDC, 2010).  Targets for blocking parasite development are at the critical steps in the life cycle 
such as the step where the parasite interacts with the epithelium in the mosquito midgut (red 
arrow, Figure 3). 
1.4 Transmission Controls of Malaria 
One avenue for controlling the spread of malaria is through the control of parasite 
transmission, either by directly affecting the insect or through genetic engineering of the insect, 
rendering it unsuitable for the parasite. Control options in which the insect is directly affected 
include killing the insect with insecticides, bed nets impregnated with insecticides, the use of 
attractants and traps, and controlling the larval habitat.  These methods are not always possible or 
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 effective.  For instance a country needs to be able to afford the control option and the people of 
the country need to be willing to use the control option.  Additionally, many countries lack the 
infrastructure to educate their people about transmission control methods.  Also of consideration 
is resistance to insecticides arising from frequent, high-volume use (Hemingway, 2000). 
Two current genetic models for hindering the Plasmodium parasite include transgenesis, 
in which the mosquito host is manipulated, and paratransgenesis, in which the bacteria inhabiting 
the mosquito host are altered.  Both of these methods pose the similar issue of releasing a 
genetically altered, living organism into the environment.  Transgenesis models have not been 
only created for malaria; other vector borne diseases have been targeted as well.  A few 
transgenesis models for malaria have been created which show great promise. One transgenesis 
model was created using a blocking protein that reduces oocyst formation by 81.6% on average. 
Another model promoting increased amounts of a naturally occurring peptide reduced oocyst 
formation by 80% on average (Ito et al., 2002; Abraham et al., 2005).  However, one challenge 
with existing transgenic mosquito models is reduced fitness such that the transgenic mosquitoes 
cannot survive in the wild (Abraham et al., 2005; Enserink, 2002).   
Paratransgenesis is an appealing alternative to transgenesis because the varying mosquito 
midgut microflora typically provide several bacterial species to work with.  Researchers have 
discovered a different profile of species of bacteria in each mosquito midgut; Straif et al. found 
the same majority bacterial genus in only 3% of studied Anopheles mosquitoes while Gonzalez-
Ceron found that the majority of mosquitoes had no cultivatable bacterial inhabitants (Straif et 
al., 1998; Gonzalez-Ceron et al., 2003).  This means that in order to create a widespread 
paratransgenesis model to fight mosquito borne diseases, a bacterial strain may need to be 
adapted to live in the mosquito gut prior to any genetic modifications (Riehle et al., 2005).  It is 
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 also of note that the number of bacteria increase exponentially when the mosquito takes a blood 
meal; this may or may not assist with the efficiency of a paratransgenic model (Riehle et al. 
2005).  Another consideration in the development of a paratransgenic model in mosquitoes is 
that only one bacterial genus, Asaia, is passed from generation to generation meaning that any 
paratransgenesis model would need to target each generation of adult mosquitoes (Favia, 2008; 
Riehle et al., 2005). 
While transgenesis and paratransgenesis are both actively researched in the lab; there is 
no consensus on how they can be implemented in the natural world (James, 2011).  The 
Cartagena treaty, adopted in 2003 by 168 countries, is an agreement on the handling, transport, 
and use of living modified organisms; however, transgenic and paratransgenic organisms are not 
thoroughly covered in the treaty (Secretariat, 2000).  It is safe to say that safety standards as 
stringent as those required for vaccine trials will be required if not even more restrictive due to 
the potential effects on human inhabitants of test areas who have not agreed to participate in the 
study (Enserink, 2002).  Most researchers would agree that preliminary cage tests need to be 
conducted but choosing locations for any field tests will prove difficult as they should occur in 
an area from which it is difficult for the mosquitoes to escape (Enserink, 2002).  Any field test 
will need to be handled with utmost care and community awareness so as not to create health 
hazards and/or bad publicity leading to public opposition of field tests and the inability to use 
any new genetic tools that are being created around the world (Subbaraman, 2011).   
Researchers have discovered a peptide that is capable of hindering the development of 
Plasmodium in the mosquito host by competing with the parasite for binding to the microvilli of 
the mosquito midgut.  Salivary gland and midgut peptide 1 (SM1) was described by Ghosh et. al. 
to potentially competitively bind to the same ligand on the mosquito midgut lumen as the malaria 
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 parasite Plasmodium berghei in mice (Ghosh et. al., 2001).  This twelve amino acid peptide 
strongly inhibits the parasite from entering the salivary glands and crossing the midgut epithelia 
(Ghosh et. al., 2001). 
1.5 Combining Phage Display and Vector Borne Disease Control 
The intention here is to develop a novel system to deliver the SM1 peptide to the 
mosquito gut to inhibit the life cycle of the parasite in the mosquito.  The use of phages and 
phage display technology is proposed in a method we call phagotransgenesis. This thesis 
describes preliminary work to develop a phage display system using only one genetic element to 
aid in the prevention of the transmission of the malaria parasite and expand that technology to 
aid in the prevention of the transmission of other insect borne parasites. 
Here it is hypothesized that any filamentous phage and its host can be used for foreign 
peptide production and expression with only one genetic element.  Furthermore it is 
hypothesized that a foreign gene inserted downstream of the major coat protein in filamentous 
phages will be expressed by the same promoter.  Because the major coat protein gene is highly 
expressed it is assumed that the inserted foreign gene will also be highly expressed.  
Due to the ultimate goal of using phages as in phage display to block the development of 
the malaria parasite in the anopheline mosquito, a bacteria found to be a natural inhabitant of the 
mosquito gut was selected.  Through an extensive literature review a list of bacteria found to be 
naturally occurring in the gut of anopheline mosquitoes was compiled (Table 2).   
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Table 2: Bacteria naturally found in the mosquito midgut 
 
Mosquito Bacteria Reference 
Anopheles 
Albimanus 
(Mexico) 
Serratia marcescens, Enterobacter 
cloacae,Enterobacter amnigenus 2, Enterobacter 
sp., and Serratia sp. 
GONZALEZ-CERON et 
al., J. Med. Entomol. 
40(3): 371Ð374 (2003) 
 
Anopheles 
darlingi (South 
America) 
Aeromonas, Pantoea and Pseudomonas*, 
Enterobacter hormaechei-cluster 
TERENIUS et al., 
Marinotti J. Med. 
Entomol. 45(1): 172Ð175 
(2008) 
 
Anopheles 
gambiae, 
Anopheles 
funestus (Africa) 
Nocardia corynebacterioides, Acidovorax 
temperans, Mycoplasma wenyoniid, 
Stenotrophomonas maltophilia, Stenotrophomonas 
maltophilia, Stenotrophomonas sp., Spiroplasma sp., 
Paenibacillus sp., Anaplasma ovis, Ehrlichia sp.. 
Aeromonas hydrophila, Aeromonas sp. 
 
Lindh, Olle Terenius, and 
Ingrid Faye Appl Environ 
Microbiol. 2005 
November; 71(11): 7217–
7223. 
Culex 
quinquefasciatus 
Acinetobacter junii, Ac. calcoaceticus, Aeromonas 
culicicola, Bacillus thuringiensis, Microbacterium 
oxydans, Pantoea agglomerans, Pseudomonas 
aeruginosa*, Staphylococcus epidermidis, 
Stenotrophomonas maltophila 
PIDIYAR,Am. J. Trop. 
Med. Hyg., 70(6), 2004, 
pp. 597–603 
*Shown in red are the bacteria species selected for the present work. 
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 From this list, Pseudomonas aeruginosa was selected because it is well characterized and 
is a host to well characterized filamentous bacteriophages.  It was important that the selected 
bacteriophages have a small genome to make genetic manipulations possible.  Pseudomonas 
aeruginosa strain PAO1 phage Pf3 is a highly characterized and studied filamentous phage 
which has a known genome of 5833 nucleotides. 
As a proof of principle, Pseudomonas aeruginosa strain PAO1 specific filamentous 
phage Pf3 was first used to express EGFP, a reporter gene.  The gene coding for EGFP was 
placed immediately downstream of gene VIII, the major coat protein gene.  After inserting the 
EGFP gene into the Pf3 genome, creation of a type 88 phage display system using EGFP in Pf3 
was attempted.  Any phage coat protein may be used for phage display, however gene VIII, the 
major coat protein, is the most popular.  The major coat protein was used here due to the high 
number of copies of the protein required to create a phage particle.  As previously described, 
three types of phage display may be accomplished using the major coat protein: Type 8, Type 
8+8, and Type 88.  Type 88 was chosen because Type 88 typically produces a viable phage 
particle with a coat comprised of mostly wild type major coat protein and a few fused coat 
proteins. In this construct, a second copy of the major coat protein gene is fused to a foreign 
peptide gene and inserted into the wild type phage genome.   
Subsequent to genetic manipulations of phage Pf3 to insert the EGFP gene, similar 
genetic manipulations were conducted to create a phage Pf3 that expressed the SM1 gene.  This 
Pf3-SM1 construct is believed to express SM1 fused to a second copy of the Pf3 major coat 
protein such that it is on the phage coat as in Type 88 phage display.  As an extension of this 
approach, EGFP expression systems similar to the initial Pf3-EGFP construct were created in 
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Pseudomonas bacteriophage Pf1 and Escherichia coli bacteriophage M13 such that the EGFP 
gene was not fused to the major coat protein. 
 2. Materials and Methods 
 
 
 
2.1 Genetic Engineering of bacteriophage Pf3 to Express the Enhanced Green       
Fluorescent Protein (EGFP) Gene 
  2.1.1 PCR Amplification 
 Due to the small genome size of phage Pf3, the entire genome can be amplified using 
polymerase chain reaction (PCR).  We amplified the whole genome of bacteriophage Pf3 using 
proofreading polymerase (Exact Polymerase, 5 Prime, Gaithersburg, MD) by PCR using the 
following program:  95 C 5min (94 C 30sec, 58 C 30sec, 72 C 14min)x35 14 C forever.  
Oligonucleotide primers were designed such that PCR resulted in the linearization of the Pf3 
phage circular DNA with the opening point of the circular DNA between gene VIII and the 
transcription termination signal of the phage genome (Table 3 and Figure 5).   
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 Table 3: Oligonucleotides for the genetic engineering of bacteriophage Pf3 with the EGFP gene 
 
Primer Name Primer Sequence 
aFor amplification of the Pf3 genome 
     Pf3MCP50upSpeI AGACCAACTAGTGCCAAAAGCCCAAGGACGGATC 
     Pf3MCP50dwBglII CGACCAGATCTCTCAATCGTTATAAGGGGGCTTCG 
bFor amplification of the EFGP gene 
     EGFPFXbaI ACATCTAGAAAGGAGATATATACATGAGTAAAGGAGAAGAACTTTTC 
     EGFPFRBamHI CCTGGATCCTTATTTGTATAGTTCATCCATGC 
cFor sequencing around the insertion site 
     Pf3-8_seq2 TGGGCTGAACGTTCAGATTTGC 
     Pf350R_seq GAGCAACAATCAAACGACCCT 
dFor amplification of the Pf3-G10 genome 
     G10upBHI ACCGGATCCTTTGTATAGTTCATCCATGCCATG 
     Pf3MCP50dwSpeI CACACTAGTCTCAATCGTTATAAGGGGGCTTC 
eFor assembling and amplifying the Pf3 modMCP gene 
     modMCPF ATG CAA TCC GTG ATT ACC GAT GTG ACG GGC CAA CTG ACA GCT GTG CAA GCT GAT ATC ACC ACC ATT GGT GGT GCC ATT ATT GTT 
     modMCPstopc TCA AAA GAA TTG CGC TTT GAT CCA ACG AAT ACC CAG CAC AAC GGC GGC CAG AAC AAT AAT GGC ACC ACC AAT GGT GGT GAT ATC 
     8hingeBgIIF CCTAGATCTGGTGGAGGCTCAGGCGGAATGCAATCCGTGATTACCGATG 
     8XbaIR CACTCTAGATCAAAAGAATTGCGCTTTGATCC 
 
aOligonucleotide primers for linearizing the Pf3 phage genome and inserting the EGFP gene 
amplified with oligonucleotide primers EGFPFXbaI and EGFPFRBamHIb. 
cOligonucleotide primers for amplification and sequencing of the regions around the insertion 
site.  
dOligonucleotide primers for linearizing the Pf3-G10 phage genome and inserting the modMCP  
gene assembled with oligonucleotide primers modMCPF and modMCPstopc and amplified with 
8hingeBgIIF and 8XbaIR e.  
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Figure 5:Insertion site of EGFP in the Pf3 genome.  EGFP gene was inserted between gene VIII 
which codes for the Major Coat Protein of Pf3 and the phage transcription termination signal.  The 
EGFP gene was immediately preceded by a ribosomal binding site.  Genome map created using 
CGView. 
      24 
 
  
Restriction enzyme recognition sequences were added to each oligonucleotide primer 
such that the resulting linear DNA had a Spe I site on one end and a Bgl II site on the other end 
(Figure 6).  
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Figure 6: Steps for constructing the recombinant phage Pf3-G10.  The genome of 
bacteriophage Pf3 is amplified by PCR and digested with restriction enzymes.  The 
oligonucleotide primers used to linearize Pf3 are shown by the small black lines leading 
away from the opening site indicated by the blue line.  The EGFP gene is amplified from 
a plasmid and digested with restriction enzymes.  The two digested fragments are then 
ligated together to form a double stranded recombinant molecule. 
  
The EGFP gene was amplified by PCR with a proofreading enzyme (Exact Polymerase, 5 
Prime, Gaithersburg, MD).  Oligonucleotide primers for the reaction were designed such that the 
entire gene was replicated (Table 3).  Restriction enzyme recognition sites were added to each 
primer such that the result of the PCR was double-stranded, linear DNA with a restriction 
enzyme recognition site on each end (Figure 4).  Additionally on the forward priming 
oligonucleotide, the nucleotide sequence of a known ribosomal binding site (RBS) of several 
genes of Pseudomonas was included (Avichezer, 1992; Shine and Dalgarno, 1975). 
2.1.2 Purification of PCR Products  
The PCR products were purified using the magnetic beads AMPure® XP (Ampure, 
Beckman Coulter Genomics, Danvers, MA) according to the manufacturer’s protocol. Briefly, 
90 l of the magnetic bead suspension are added per 50 l of PCR mixture, homogenized and left 
for 5 minutes at room temperature.  A magnetic base is used to separate the magnetic beads 
containing the DNA from the liquid.  After the samples had been on the magnetic base long 
enough for the beads to form a firmly aggregated pellet on the tube wall, approximately 5 
minutes, the liquid is carefully removed.  Two hundred microliters of 70% ethanol are used to 
rinse the pellet twice and the tube was allowed to dry in a 37 C air incubator.  Once dry the tube 
is removed from the magnetic holder and the magnetic beads were suspended in 20 l of water to 
elute the bound DNA.  The suspension is allowed to sit at room temperature for 5 minutes then 
placed back on the magnetic base until the beads forme a firmly aggregated pellet on the tube 
wall (approximately 5 minutes).  The liquid containing the DNA was recovered and stored at – 
20 C until use. 
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 2.1.3 Restriction Enzyme Digestion of Purified PCR Products 
 The Pf3 DNA PCR product was digested overnight in a 37 C water bath with the 
restriction enzymes using the suggested double digestion manufacturer’s buffers (New England 
Biolabs, Inc., Ipswich, MA).  Different restriction enzymes were selected to promote correct 
orientation of an inserted gene into the opening point of the Pf3 genome.  This strategy was used 
throughout the entire project. 
 The EGFP-containing PCR product was digested overnight in a 37 C water bath with the 
restriction enzymes Xba I and Bam HI (New England Biolabs, Inc., Ipswich, MA).  Different 
restriction enzyme sites compatible with those used in Pf3 were selected for the EGFP gene so 
not to recreate these restriction enzyme sites after ligation.  This was done so that the same 
restriction enzyme sites could be re-introduced in future engineering without the concern of 
cutting the DNA at sites other than the desired ones. 
2.1.4. Ligation of the Digested PCR Products  
Digested Pf3 and the PCR amplified EGFP DNA were mixed at the ratio of 1 Pf3 to 5 
EGFP DNA molecules and ligated using T4 DNA ligase (New England Biolabs, Inc., Ipswich, 
MA) in a volume of 20 l.  The reaction was left at room temperature overnight.  The ligated 
DNA was purified with magnetic beads as previously described above and used for transfection 
of P. aeruginosa PAO1 competent cells. 
2.2 Transfection of Pseudomonas. aeruginosa PAO1 with the Ligated DNA 
2.2.1 Competent Cell Preparation  
 The method used for transfection was electroporation.  Electro-competent P. aeruginosa 
PAO1 cells were prepared as described by Choi et al (2005). Briefly, PAO1 cells were 
inoculated in 5 ml of LB broth supplemented with 50 ug/ml of kanamycin and grown overnight.   
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 One and a half milliliters of the overnight culture was centrifuged at room temperature for 4 
minutes at 17,000xg to pellet the cells.  The supernatant was removed, the cells re-suspended in 
100 l of 10% sucrose then re-pelleted.  This procedure was repeated three times at room 
temperature.  The final cell pellet was re-suspended in 40 l of ten percent sucrose.  The electro-
competent cells were stored on ice or used immediately. 
2.2.2 Transfection 
 Four microliters of ligated Pf3-EGFP DNA were added to 40 l of freshly prepared 
competent cells.  The sample was transferred into an electroporation cuvette with a 2 mm gap 
(Fisher Scientific, Pittsburg, PA) and electroporated using the following electroporator settings: 
200 Ohms resistance, 25 FD capacity, and 2.5 set volts with 2.51 actual volts and a time 
constant of 3.9 seconds (Biorad Gene Pulser II, Hercules, CA).  Immediately after 
electroporation, one milliliter of super optimal broth with catabolite repression (SOC; Hanahan, 
1983) was added to the cell suspension, and two different aliquots were plated, 100 l and 300 
l, on LB broth agar plates containing 50 g/ml of kanamycin with 3 ml of 0.75% top agar.  To 
the 100 l cell aliquot, 200 l of fresh PAO1 cell culture was added prior to plating to insure a 
bacterial lawn with proper density. The plates with the transfected PAO1 cells were incubated at 
room temperature overnight.  
2.3 DNA Sequencing of Engineered Phage Pf3 Expressing EGFP 
2.3.1 Screening of Recombinant Phages by Fluorescence Visualization 
 Transfected PAO1 cells expressing EGFP were visualized in a gel imager (Alpha Imager, 
Alpha Innotech, Santa Clara, CA) equipped with a 488 nm wavelength filter on the UV light 
source.  EGFP fluorescence was recorded using a camera with an emission filter of 500 nm 
wavelength.  Fluorescing phage plaques were isolated and further characterized.   
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  2.3.2 Amplification of Recombinant Pf3 at the EGFP Insertion Site and DNA 
Sequencing 
To confirm insertion of the EGFP gene into the Pf3 genome, a segment of the 
recombinant phage genome containing the EGFP gene was amplified by PCR using Hotmaster 
Taq DNA polymerase (5 Prime, Gaithersburg, MD). PCR primers used for the amplification are 
shown in Table 2; one anneals upstream of the EGFP gene insertion site while the other anneals 
downstream of the same site such that an amplified fragment contains the EGFP gene as well as 
the segments of the Pf3 genome on either side of the inserted gene. Amplified fragments from 
the screened recombinant phages were visualized by agarose gel electrophoresis and compared to 
lambda DNA cut with the restriction enzyme Hind III (New England Biolabs, Inc., Ipswich, MA) 
to estimate the lengths of the amplified fragments. Fragments showing the expected length were 
submitted the VCU Nucleic Acid Research Facilities (NARF) for sequencing using the Sanger 
method (Figure 7).  
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Figure 7: Amplification of recombinant phage Pf3-G10 and wild type Pf3 genomes.   The 
phage constructs are marked and compared to lambda DNA cut with the Hind III restriction 
enzyme.  Markers on the right indicate the nucleotide size of each band in the size marker. 
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 2.4 Construction of Type 88 Phage Display in Phage Pf3 with EGFP  
  2.4.1 Recombinant Phage DNA Manipulation 
 The genome of the Pf3 phage engineered to express EGFP (Pf3-G10) was amplified by 
PCR with primers shown in Table 2 so that it was linearized with the EGFP gene on one end and 
the phage transcription termination signal on the other end (Velocity DNA Polymerase, Bioline, 
Taunton, MA).  The modified major coat protein gene (modMCP) was produced by annealing 
oligonucleotides and then amplified from the annealed oligonucleotides using primers with 
restriction enzyme recognition sites (Table 2).  This was not an exact replica of the MCP gene 
already present in the Pf3 genome; approximately every 6th codon was modified for a total of 
seven modified nucleotides.  Due to synonymous codon usage, the amino acid sequence was not 
modified (Figure 8).  Based on Pierce, this created a more stable phage genome than having two 
identical copies of the MCP because it decreased the likelihood of genetic deletions in the phage 
resulting from homologous recombination (Pierce, 1989).   
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Pf3 MCP gene     
ATGCAATCCGTGATTACTGATGTGACAGGCCAACTGACAGCGGTGCAAGCTGATATCACTACCA
TTGGTGGTGCTATTATTGTTCTGGCCGCTGTTGTGCTGGGTATTCGCTGGATCAAAGCGCAATT
CTTTTGA 
Pf3 modMCP gene  
ATGCAATCCGTGATTACCGATGTGACGGGCCAACTGACAGCTGTGCAAGCTGATATCACCACCA
TTGGTGGTGCCATTATTGTTCTGGCCGCCGTTGTGCTGGGTATTCGTTGGATCAAAGCGCAATT
CTTTTGA 
Amino-acid sequence of Pf3 MCP = modMCP    
MQSVITDVTGQLTAVQADITTIGGAIIVLAAVVLGIRWIKAQFF*   
 
Figure 8: Changes of bases in the Pf3 MCP gene sequence for the synthesis of the modMCP 
gene.  The 7 bases changed in modMCP relative to the wild type MCP gene are shown red. 
These changes did not affect the amino-acid sequence of modMCP.                                                    
   2.4.2 PCR Amplification Digestion with Restriction Enzymes  
The amplified Pf3-G10 genome was digested with restriction enzymes Bam HI and Spe I 
while the amplified modMCP gene was digested with Bgl II and Xba I (New England Biolabs, 
Inc., Ipswich, MA). Magnetic beads were used along with a magnetic base to concentrate and 
purify the PCR product digestions as previously described (Ampure, Beckman Coulter 
Genomics, Danvers, MA).  
2.4.3 Ligation  
Digested Pf3-G10 DNA and modMCP DNA were mixed at a ratio of 1 Pf3-G10 to 5 
modMCP DNA molecules and ligated using T4 DNA ligase and the manufacturer’s buffers 
(New England Biolabs, Inc., Ipswich, MA) in a volume of 20 l.  The reaction was left at room 
temperature overnight.  The ligated DNA was purified with magnetic beads as previously 
described above and used for transfection of PAO1 competent cells.  Here a modified copy of the 
Pf3 major coat protein was inserted so that it was hinged to the EGFP gene. 
Competent cell preparation, transfection, and verification of expression were conducted 
as previously described in 2.2 and 2.3.  The resulting recombinant phage was named Pf3-G10-
SH (Figure 9). 
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Figure 9: Steps for constructing the recombinant  phage Pf3-G10-SH.  The genome of 
bacteriophage Pf3-G10 was amplified and digested with restriction enzymes.  The point of 
linearization is indicated by the red line an d the oligonucleotide primers are indicated by the 
small green line and the small black line moving away from the point of linearization.  The 
modified MCP gene was created by annealing two oligonucleotides together and then amplified 
by PCR and digested with restriction enzymes.  The two digested fragments were then ligated 
together to form a double stranded recombinant phage. 
 
      35 
 
 2.5 Non-denaturing SDS-PAGE 
Cultures of uninfected PAO1, wild type Pf3 infected PAO1 cells, Pf3-G10 infected 
PAO1 cells, and Pf3-G10-SH infected PAO1 cells were grown for 18 hours in LB supplemented 
with 50 g/ml of kanamycin with shaking at room temperature.  The cells from 1.5 ml of culture 
were harvested by centrifugation and the supernatant was removed to a fresh tube.  The cell 
fraction was treated with 1.5 ml BugBuster Protein Extraction Reagent (EMD Chemicals, 
Gibbstown, NJ) which lysed the cells without denaturing proteins.  Each sample from the lysed 
cell pellet and from the supernatant was passed through a .22 m syringe filter and then 
concentrated using 10K column filters (Millipore, Billerica, MA).  Samples were loaded on to a 
pre-cast 12% polyacrylamide gel (Mini-Protean TGX, Biorad, Hercules, CA) after being 
combined with Native Sample Buffer (Biorad, Hercules, CA).  The gel was run for 30 minutes at 
220V and samples expressing EGFP were visualized in the gel imager equipped with a 488 nm 
wavelength filter on the UV light source.  EGFP fluorescence was recorded using a camera with 
an emission filter of 500 nm wavelength. 
2.6 Construction of Pf3-SM1(4) 
 2.6.1 SM1(4) DNA Amplification 
The SM1(4) cassette consists four tandem copies of the SM1 peptide coding sequence 
and was amplified from the plasmid PDB48(SM1)4, kindly provided by Dr. Sibao Wang from 
Johns Hopkins School of Public Health.  Oligonucleotide primers SM1-4FATGblunt and SM1-
4RBHI were used to amplify the SM1(4) cassette (Table 4).   
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 Table 4: Oligonucleotides for the genetic engineering of bacteriophage Pf3-G10-SH with 
SM1(4) gene cassette 
Primer Name Primer Sequence 
aFor amplification of Pf3-G10-SH genome and replacement of EGFP gene 
     G10EGFPBH1dwn ACCGGATCCAGTAAAGGAGAAGAACTTTTCAC 
     G10RBSup CATGTATATATCTCCTTTCTAGTGCC 
bFor amplifying SM1(4) gene cassette 
     SM1-4FATGblunt  ATGGCTAGCCCCTGTCAGCG 
     SM1-4RBHI CCCAGGTCCCGGGGGTGGATCCGT 
cFor sequencing around the insertion site 
     Pf3-8_seq2 TGGGCTGAACGTTCAGATTTGC 
     Pf350R_seq GAGCAACAATCAAACGACCCT 
 
aOligonucleotide primers for linearizing Pf3-G10-SH phage genome and replacing the EGFP 
gene with the SM1(4) gene cassette amplified with oligonucleotide primers SM1-4FATGblunt 
and SM1-4RBHIb. 
cOligonucleotide primers for amplification and sequencing of the regions around the insertion 
site. 
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 2.6.2 Ligation, Transfection, and Testing Putative Recombinant Phages 
The amplified SM1(4) cassette was ligated into Pf3-G10-SH linearized by PCR with 
oligonucleotide primers listed in Table 4. The PF3-SM1(4) ligated DNA was transfected into 
competent PAO1 cells as described previously in 2.2 and 2.3 (Figure 10). 
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Figure 10: Steps for constructing a the recombinant phage Pf3-SH-SM1(4).  The genome of 
bacteriophage Pf3-G10-SH is amplified and digested with restriction enzymes.  The primers 
are indicated by the small black line and small pink line moving away from the EGFP gene.  
The SM1(4) cassette was amplified from plasmid PDB48(SM1)4.  The two digested 
fragments were then ligated together to form a double stranded recombinant phage. 
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 2.7 Construction of Pf1-G and M13-G 
 Manipulations of phages Pf1 and M13 were conducted as previously described to 
construct phage Pf3-G10.  The EGFP oligonucleotides used for Pf1 and M13 were the same as 
those used for phage Pf3.  Oligonucleotide primers were unique for each phage; those for phage 
Pf1 can be found in Table 5 and those for phage M13 can be found in Table 6.   
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 Table 5: Oligonucleotides for the genetic engineering of bacteriophage Pf1 with the EGFP gene 
 
Primer Name Primer Sequence 
aFor amplification of the Pf1 genome 
     Pf1MCP5upSpeI AGACCAACTAGTCACACCGACCAGAGCACCCG 
     Pf1MCP5dwnBglII CGACCAGATCTGTTGGGGGCGTTCTTCGCCG 
bFor amplification of the EFGP gene 
     EGFPFXbaI ACATCTAGAAAGGAGATATATACATGAGTAAAGGAGAAGAACTTTTC 
     EGFPFRBamHI CCTGGATCCTTATTTGTATAGTTCATCCATGC 
cFor sequencing around the insertion site 
     Pf18R_seq CGGTGAACTGTCCATTGAGC 
     Pf1MCPF_seq CCTCGTTCCGCAACCTGT 
 
aOligonucleotide primers for linearizing the Pf1 phage genome and inserting the EGFP gene 
amplified with oligonucleotide primers EGFPFXbaI and EGFPFRBamHIb. 
cOligonucleotide primers for amplification and sequencing of the regions around the insertion 
site. 
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 Table 6: Oligonucleotides for the genetic engineering of bacteriophage M13 with the EGFP gene 
 
Primer Name Primer Sequence 
aFor amplification of the M13 genome 
     M138dwnSpeI CAACTAGTCTTTTGGAGCCTTTTTTTTTGGAGATTTTC 
     M138upBclI CGACCTGATCAGAGCCTTTAATTGTATCGGTTTATCAG 
bFor amplification of the EFGP gene 
     EGFPFXbaI ACATCTAGAAAGGAGATATATACATGAGTAAAGGAGAAGAACTTTTC 
     EGFPFRBamHI CCTGGATCCTTATTTGTATAGTTCATCCATGC 
cFor sequencing around the insertion site 
     M138dwn_seq GCGCAACTATCGGTATCAAGC 
     M138up_seq TCAACAGTTTCAGCGGAGTGAG 
 
aOligonucleotide primers for linearizing the Pf1 phage genome and inserting the EGFP gene 
amplified with oligonucleotide primers EGFPFXbaI and EGFPFRBamHIb. 
cOligonucleotide primers for amplification and sequencing of the regions around the insertion 
site. 
      42 
 
       43 
 
2.8 Identification of Promoter Sequences 
 An online promoter prediction program (Neural Network Promoter Prediction, Berkeley 
Drosophila Genome Project) was used to predict promoters in the genomes of Pf3, Pf1, and M13 
in order to predict gene expression in these phages.   
 3.  Results 
 
 
 
3.1 Insertion of EGFP Gene into the Pf3 Genome (Pf3-G10) 
 PCR amplification was conducted on potentially recombinant phages with 
oligonucleotides that amplified a segment of the phage genome containing the EGFP gene.  The 
PCR product was analyzed by agarose gel electrophoresis and the results are shown in Figure 7.  
Recombinant phages that produced PCR products about 1300 bases long, the expected length of 
the EGFP gene combined with flanking Pf3 gene segments, were sequenced (Figure 11).   
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Figure 11: The DNA sequence of the EGFP gene insertion site in Pf3-G10. The 3’ end of the 
original Pf3 MCP gene is shown in the second line. The ribosomal binding site (RBS) 
sequence and its position in relation to the ATG of the EGFP gene is shown in the third line. 
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 A copy of the EGFP gene was successfully inserted into the wild type Pf3 genome to 
produce a recombinant phage named Pf3-G10.  This includes the ribosomal binding site (Shine 
and Dalgarno, 1975) as characterized in Pseudomonas (Avichezer, 1992).   
 3.2 Expression of EGFP Gene by Phage Pf3 
EGFP fluorescence was observed on phage plaques on bacterial lawns, and in liquid 
bacterial cultures (Figures 12).  The plaque morphology of the recombinant phage is similar to 
that of the wild type Pf3 and is shown in Figure 12 (A and B).  Under the fluorescent microscope 
cells infected with pF3-G10 is readily seem     
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BA 
C
Figure 12: Pseudomonas aeruginosa bacteria infected with Pf3 engineered with the EGFP 
gene (Pf3-G10). A) Colonies of G10 infected cells viewed under white light. B) Colonies 
of G10 infected cells viewed under UV light through a filter of 488 nm. C) Liquid culture 
of phage infected cells (100X) under the microscope with filter of 488 nm, photo courtesy 
of Najla Matos of the facilities of Instituto de Pesquisas em Doenças Tropicais 
(IPEPATRO), Porto Velho, RO, Brazil. 
 3.3 Creating Type 88 Phage Display in Pf3 
3.3.1 Synthesis of Modified Major Coat Protein (modMCP) Gene  
 To create modified Pf3 major coat protein, two partially overlapping, 
complimentary oligonucleotides were synthesized and annealed.  The nucleotide sequence of the 
major coat protein was modified while the amino acid sequence remained the same.  This was 
done because work by Pierce shows an increased possibility of genetic deletions of a second 
exact copy of a gene inserted into a bacteriophage (Pierce, 1989).  This fragment was then 
amplified by PCR and analyzed by agarose gel electrophoresis (Figure 13).   
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A 
 
ATGCAATCCGTGATTACCGATGTGACGGGCCAACTGACAGCTGTGCAAGCTGATATCACCACCATTGGTGGTGCCATTATTGTT                                                          
   CTATAGTGGTGGTAACCACCACGGTAATAACAAGACCGGCGGCAACACGACCCATAAGCAACCTAGTTTCGCGTTAAGAAAACT 
 
ATGCAATCCGTGATTACCGATGTGACGGGCCAACTGACAGCTGTGCAAGCTGATATCACCACCATTGGTGGTGCCATTATTGTTGACCGGCGGCAACACGACCCATAAGCAACCTAGTTTCGCGTTAAGAAAACT 
 
 
 
B 
 
CCTAGATCTGGTGGAGGCTCAGGCGGAATGCAATCCGTGATTACCGATG    
   ATGCAATCCGTGATTACCGATGTGACGGGCCAACTGACAGCTGTGCAAGCT|ACCGGCGGCAACACGACCCATAAGCAACCTAGTTTCGCGTTAAGAAAACT 
          CCTAGTTTCGCGTTAAGAAAACTAGATCTCAC  
Figure 13. Synthesis of the Pf3 modified major coat protein.  A) Oligonucleotides 
modMCPF and modMCPStopC, shown in red, were annealed to create a nucleotide 
sequence with overhanging ends.  The consensus sequence of the two anneal 
oligonucleotides is shown in green.  B) The annealed oligonucleotides, shown in green 
with a purple line indicated a break in the sequence, were then amplified by PCR using 
oligonucleotides 8XbaIR and 8hingeBgIIF, shown in blue, which contained restriction 
enzyme recognition sites.  
  
3.3.2 Insertion of modMCP into Pf3-G10 Genome (Pf3-G10-SH) 
After transfection with the Pf3-G10 genome with the inserted modified MCP, potentially 
recombinant phages were amplified by PCR and sequenced.  From sequence analysis it can be 
seen that the modified MCP gene has been successfully inserted into the previously engineered 
phage Pf3-G10.  This phage, called Pf3-G10-SH for self-helper, could also be viewed as glowing 
plaques on a lawn of PAO1 cells.  It can be seen that EGFP is being expressed on the lawn of 
PAO1 where there are plaques (Figure 14).   
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Figure 14: Pseudomonas aeruginosa bacteria infected with Pf3-G10 engineered with a 
modified MCP gene (Pf3-G10-SH) A) Colonies of Pf3-G10-SH infected cells viewed under 
white light. B) Colonies of SH infected cells viewed under UV light. 
 3.4 Fate of the EGFP in PAO1 Infected with Pf3-G10 and Pf3-G10-SH . 
Due to the ultimate goal of developing a phagotransgenesis model to combat the malaria 
parasite, it is important to know the location of the expressed foreign peptide.  For applications in 
disease research it is imperative that the foreign peptide be released from the cell so that it may 
come in contact with the extracellular environment.  To analyze the location of the expressed 
foreign protein, a non-denaturing protein gel of both the supernatant and cell fractions of 18 hour 
culture of uninfected PAO1 cells, PAO1 cells infected with wild type Pf3, PAO1 cells infected 
with Pf3-G10 and PAO1 cells infected with Pf3-G10-SH was conducted (Figure 15).   
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Figure 15. Non-denaturing Protein Gel of Uninfected PAO1 cells, PAO1 Cells Infected with 
Wild Type Pf3, PAO1 Cells Infected with Pf3-G10, PAO1 Cells Infected with Pf3-G10-SH, 
and Their Respective Supernatants photographed under UV light with a black and white 
camera.  There are clearly no bands in either of the PAO1 cell column or in the PAO1 cell 
supernatant column.  The Pf3 infected PAO1 cells show no bands in either the cell or 
supernatant columns.  Both clones Pf3-G10(*) and Pf3-G10-SH(^) contain a copy of the EGFP 
gene and have visible bands shown on the gel in both the cell fraction columns and the 
supernatant fraction columns.  This indicates that not only is EGFP being produced by the cell, 
it is located outside of the cell. 
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 The cell fraction which would contain any foreign protein that had not been secreted from the 
cells was separated by filtration from the supernatant fraction which contained any proteins 
secreted from the cells.  Fluorescing bands of EGFP protein can be seen to indicate the presence 
of the EGFP protein in the supernatant of both the Pf3-G10 and the Pf3-G10-SH as well as in the 
cell fraction of both Pf3-G10 and Pf3-G10-SH.  The Pf3-G10-SH lane indicates a band of protein 
that migrated slower than the band produced by Pf3-G10 which indicates that the EGFP protein 
produced by Pf3-G10-SH infected PAO1 is larger than that produced by Pf3-G10 infected PAO1 
due to additional amino acids that were fused downstream of the EGFP gene in an attempt to 
create a fusion protein.   
3.5 Sequence Analysis of Pf3-G10-SH 
Upon further analysis, it was discovered that even though the fully modified MCP was 
successfully inserted into engineered phage Pf3-G10, the modified MCP is not in the same 
reading frame as the EGFP gene and therefore EGFP is not fused to modMCP protein.     
3.6 Insertion Replacement of SM1 Gene into Pf3-G10-SH 
Even though creation of Type 88 phage display using bacteriophage Pf3 was 
unsuccessful with EGFP, the engineered phage Pf3-G10-SH may be used as a vector for 
inserting other foreign peptides into the Pf3 genome.  The Pf3-G10-SH genome was processed as 
described above and the SM1(4) cassette was successfully inserted (Figure 16).   
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Figure 16: Insertion site of the SM1(4) gene cassette.  Above the red line, the Pf3-SH-SM1(4) 
construct sequence can be seen to contain the end of the Pf3 MCP gene and the beginning of the 
SM1(4) gene cassette as well as the RBS shown in the blue box.  Below the red line, the Pf3-SH-
SM1(4) construct sequence can be seen to contain the end of the SM1(4) gene cassette as well as 
the beginning of the modMCP gene.  The SM1(4) gene cassette is in the same reading frame as 
the modMCP gene. 
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 3.7 EGFP Gene Expression in Phages Pf1 and M13 
Based upon similar gene organization, the same methods were used to construct 
analogous recombinant phages in filamentous phage Pf1 of P. aeuriginosa strain PAK and 
filamentous phage M13 of E. coli (Figure 17).   
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Figure 17. M13 and Pf1 phages engineered with the EGFP gene. A) Plaques of M13-G phage 
visualized by excitation UV light through a 488nm wavelength filter and emission light 
captured through a camera equipped with a 500nm wavelength filter. B) Plaques of Pf1-G 
infected cells visualized by excitation UV light through a 488nm wavelength filter and 
emission light captured through a camera equipped with a 500nm wavelength filter.   
 
 3.8 Promoter Analysis in Phages Pf3, Pf1, and M13 
With the goal of identifying putative promoters, the Berkeley Drosophila Genome 
Project’s Neural Network Promoter Prediction tool was used to predict potential promoters 
within the genomes of phages Pf3, Pf1, and, M13.  Because phages use host cell machinery for 
transcription of their genome, prokaryotic promoter regions were searched for.  A score is 
provided for predicted promoters, and the score indicates the percentage of all promoters 
recognized at that threshold, as well as the number of false positives. All promoters analyzed 
produced a minimum score of .85 indicating that 60% of all promoters were indicated with a 
false positive of 0.4% and a correlation coefficient of 0.72.  In the three analyzed phages, it can 
be seen that known or putative single stranded DNA binding protein is transcribed in frame with 
and immediately precedes the major coat protein.  This is logical since both the single stranded 
binding protein and the major coat protein are highly expressed.  Analysis of these three phages 
for potential promoters reveals at least one promoter occurring immediately prior to the start of 
the single stranded binding protein gene in each phage with two promoters prior to the start of 
the single stranded binding protein gene in phages Pf1 and M13.  Multiple putative promoters 
can be seen in all presented genome maps (Figure 18). 
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Figure 18: Alignment of bacteriophage genomes with their respective genes and putative 
promoters. For clarity, only the single stranded binding protein (SSBP) is indicated as well as the 
major coat protein (MCP) genes, and the two putative promoters located immediately upstream 
of the SSBP gene are highlighted in a blue box.  The EGFP gene insertion site in each of the 
three phage genomes is marked by a purple line. Genome maps created using CGView.
 4.  Discussion 
 
 
 
4.1 EGFP Gene Expression in phages Pf3, Pf1, and M13 
Here it is shown that the EGFP gene can be inserted downstream of the major coat 
protein of phage Pf3, Pf1, or M13 and be expressed under the control of the major coat protein 
promoter.  Since most filamentous phages have a comparable gene organization to the three 
systems that have been constructed, this suggests that any filamentous phage can be used to 
construct a similar system.  Hence, there may be unlimited potential for this technology.  
Furthermore, this expression system could be used in any environment that filamentous phages 
are found because the foreign peptide is solely dependent upon expression from the phage’s 
promoters.   
Additional characterization of the construct would need to be conducted along with 
protein size based experiments in order to determine the range of foreign peptides that may be 
expressed in this manner.  There is no reason to believe that two fused proteins could not be 
expressed in this fashion leading to the hypothesis that a foreign gene being fused to a phage 
gene could be expressed to create a Type 88 phage display system. 
4.2 Type 88 Phage Display in Pf3 with the EGFP gene 
For the ultimate goal of using phages as in phage display to block the transmission of the 
malaria parasite it is imperative that the foreign peptide be secreted from the host cell.  This is of 
such great importance because the foreign peptide must be able to compete with the malaria 
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 parasite for interaction with receptors on the midgut epithelia of the mosquito.  Creating a Type 
88 phage display system in which the foreign peptide is expressed on the phage coat would be an 
ideal system for the foreign peptide to be secreted from the host cell.  Type 88 phage display also 
meets the need of using only one genetic element.  Construction of Type 88 phage display using 
phage Pf3 was first attempted using the EGFP gene. 
Attempts to construct a phage display system with the EGFP gene on the phage coat of 
Pf3 were unsuccessful because the inserted copy of the EGFP gene was not in frame with the 
inserted modified major coat protein.  The inability to create an appropriate construct may be due 
to problems caused by proofreading polymerase used during PCR.  The enzyme that was used 
disrupts the ends of the DNA strands and may not produce the intended product; this was 
discovered well after the experiments had already been conducted and could have easily caused a 
few bases to be deleted resulting in the EGFP gene and the modMCP gene being in different 
reading frames.  Additional characterization of this engineered phage needs to be conducted and 
attempts to put the EGFP gene in frame with the modified MCP gene are underway but have 
been unsuccessful up to this point. 
The success here is in the creation of a replacement vector that can be used for insertion 
of other foreign peptides into the genome of Pf3 such that they are fused to the modified major 
coat protein and thereby displayed on the phage coat as in phage display.  One differentiating 
point between this Type 88 system and traditional phage display is the use of a promoter region. 
In traditional M13 phage display, a promoter region is inserted into the phage genome so that the 
foreign gene is expressed (Sidhu, 2001).  Here, the created system does not require a promoter to 
be inserted prior to the foreign gene in order for there to be expression.  This is likely due to the 
location in the bacteriophage genome where the foreign gene fused to the modified major coat 
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 protein is inserted.  The major coat protein is a highly expressed, phage-coded protein and here 
the inserted gene fusion is placed immediately after the major coat protein and before the 
transcription termination signal.  
4.3 Type 88 Phage Display in Pf3 with the SM1 gene 
The constructed Pf3 replacement vector was used to insert a gene cassette containing four 
copies of the SM1 gene into the Pf3 genome so that they were in frame with the modified major 
coat protein. Four tandem copies of SM1 (SM1(4)) were used because it Ito has already shown 
that the blocking effect of the protein increased with the number of copies of the protein gene 
that were being expressed but that the increase in blocking is insignificant after the fourth copy 
(Ito, 2002). 
This construct was successfully obtained but optimization is required.  As seen in Figure 
15, all of the needed pieces are present in the construct; however, there are only two bases 
between the ribosomal binding site and the beginning of the SM1(4) cassette.  This was not 
intentional and, again, is most likely a consequence of the proofreading polymerase which was 
used in the PCR amplifications.  There is no reason to believe that the SM1(4) cassette is not 
being expressed and no reason to believe that it is not fused to the modified major coat protein; 
however, optimization of the construct to introduce additional bases between the ribosomal 
binding site and the beginning of the SM1(4) cassette would be ideal. Typically in Pseudomonas 
the ribosomal binding site is found 6 to 10 nucleotides prior to the beginning of a gene 
(Avichezer, 1992, Blumer, 1999; Olins, 1988).  Using the same spacing would be ideal when 
constructing a recombinant phage to be used in Pseudomonas.  Expression would likely be 
increased with appropriate placement of the ribosomal binding site as Olins reported a 340-fold 
increase in gene expression when using a ribosomal binding site (Olins, 1988). 
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 4.4 Expressed Foreign Peptide Secretion  
As seen in Figure 14, the expressed EGFP, as well as the EGFP fused with additional 
amino acids, is being secreted from the cell.  The method of secretion is unknown and 
characterization is needed.  There are several ways that filamentous phages may be secreted from 
host cells, and the expressed EGFP is likely to use one of these methods. 
The EGFP may be simply using the host encoded secretion channel as seen in the phage 
CTXФ which uses the same host encoded channel as cholera toxin for secretion (Rakonjac, 
2011).  Alternatively, the EGFP may also be using a phage encoded secretion channel.  In either 
case the EGFP is being secreted from the host cell as desired; it is imperative that expressed 
foreign peptides be secreted from the cell so that they may interact with the extracellular 
environment.  In presented case of malaria, the SM1 peptide must be secreted from the cell so 
that it can competitively bind to the same ligand as the malaria parasite.  Secretion may be a 
distinct property of EGFP and may not be observed when other foreign proteins are inserted into 
the Pf3 genome.  Further characterization of the secretion system that is acting in the Pf3-G10 
and Pf3-G10-SH constructs needs to be conducted so that this system may be applied to other 
foreign proteins.   The method of secretion may dictate how this type of system can be used in 
the future. 
4.5 Promoter Sequence Analysis 
There is at least one putative promoter occurring immediately prior to the start of the 
single stranded DNA binding protein gene in each of the three phages that were analyzed.  This 
promoter would act to promote transcription of both the single stranded binding protein as well 
as the major coat protein and, in the Pf3, Pf1, and M13 constructs presented here, the foreign 
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 EGFP gene that was inserted into the phage genome.  There were also promoters predicted in the 
opposite direction of gene transcription which may play a role in expression control. 
Polycistronic gene transcription is highly likely because filamentous bacteriophage genes 
are spaced in tandem, without room for individual promoters and there were not promoters 
predicted prior to each gene in the phage genomes.   
In prokaryotes, there is a promoter region 10 bases upstream from the transcription start 
site and a similar structure has been described in bacteriophages (Gershenzon, 2005; Olins, 
1988).  This is consistent with the predicted promoter sequences in the genomes of phages Pf3, 
Pf1, and M13.  Here, there were promoters predicted inside of genes which further supports the 
idea that the phage genes are organized into operons to control expression levels.  Highly 
expressed genes such as the single stranded DNA binding protein and the major coat protein 
appear to be organized into an operon while the minor coat proteins appear to be organized into 
another.  When inserting a foreign gene consideration should be given to the operon the gene is 
inserted into.  Here, high expression of the foreign gene was desired so placing it within a highly 
expressed operon was helpful. 
4.6 Future Uses 
Based on the results, the future implications of foreign gene expression using the systems  
similar to those created here are tremendous.  Clearly there is a potential application in 
controlling the transmission of the malaria parasite.  While the SM1 protein blocks the 
development of the malaria parasite found to infect mice, once a similar protein is found that 
block the parasite that infects humans, a phage system that expresses that protein may be easily 
constructed following the same protocol used here. 
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 Other vector borne diseases may also be blocked using this type of system.  For instance, 
the BMAP-18 peptide, a truncated version of the bovine myeloid antimicrobial peptide – 27 
(BMAP-27) is has been reported to block the trypanosomatid parasites that cause Chagas disease 
(Haines, 2009).  Any filamentous phage-host pair found to naturally occur in the host for the 
trypanosomatid parasite may be engineered to express BMAP-18, using the same technique used 
here, thereby blocking the parasite.  Release of a genetically altered phage is more favorable than 
release of a genetically modified insect or bacteria because phages are unable to propagate 
outside of their host bacteria meaning that phagotransgenesis is more favorable than transgenesis 
or paratransgenesis in blocking vector borne parasites. 
4.7 Conclusions 
Here a foreign gene has been successfully expressed in bacteriophages Pf3, Pf1, and M13 
using the phage’s naturally occurring promoters.  This was then applied to create a Type 88 
phage display system to control the spread of the malaria parasite.  The Type 88 phage display 
system met the biggest requirement of a malaria parasite blocking system; one genetic element.  
While this phage display system has been designed for use in the control of the malaria parasite, 
alternative applications abound. 
 
 
 
 
 
 
 
      65 
 
       66 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Literature Cited
 Literature Cited 
 
 
 
Abraham, E.G., Donnelly-Doman, M., Fujioka, H., Ghosh, A., Moreira, L., and Jacobs-Lorena, 
M. (2005). Driving midgut-specific expression and secretion of a foreign protein in 
transgenic mosquitoes with AgAper1 regulatory elements. Insect Molecular Biology, 
14(3), 271-279. 
 
Ackermann, H.W. (2003). Bacteriophage observations and evolution. Research in Microbiology, 
154, 245-251. 
 
Ackermann, H.W. The Bacteriophages.  Oxford University: Oxford University Press, 2006. 
Print. 
Avichezer, D., Katcoff, D. J., Garber, N.C., and Gilboa-Garber, N. (1992). Analysis of the 
Amino Acid Sequence of the Pseudomonas aeruginosa Galactophilic PA-I Lectin. The 
Journal of Biological Chemistry, 267(32): 23023-23027. 
 
Breitbart, M. and Rohwer, F. (2005) Here a virus, there a virus, everywhere the same virus? 
Trends in Microbiology, 13(6): 278-284. 
 
Blumer, C., Heeb, S., Pessi, G., and Haas, D. (1999) Proccedings of the National Academy of 
Sciences of the United States of America, 96(24)14073-14078. 
 
Centers for Disease Control (CDC). (2010). Malaria. www.cdc.gov/malaria.  
 
Chandler, D.L. (2011). Solar Power Goes Viral. MITnews. 
www.web.mit.edu/newsoffice/2011/solar-virus-0425.html.   
 
Dang, X., Yi, H., Ham, M., Qi, J., Yun, D.S., Ladewski, R. Strano, M.S., Hammond, P.T., and 
Belcher, A.M. (2011). Nature Nanotechnology, 6: 377-384. 
 
Enserink, M. (2002). Ecologists See Flaws in Transgenic Mosquitos. Science, 297, 30-31. 
 
Favia, G., Ricci, I., Marzorati, M., Negri I., Alma, A., Sacchi, L., Bandi, C., and Daffonchio, D. 
(2008).  Bacteria of the Genus Asaia: A Potential Paratransgenic Weapon Against 
Malaria. Advances in Experimental Medicine and Biology, 627: 49-59. 
 
      67 
 
 Gershenzon NI, Ioshikhes IP (2005). "Synergy of human Pol II core promoter elements revealed 
by statistical sequence analysis". Bioinformatics 21 (8): 1295–300. 
Ghosh, Anil K., Ribolla, Paulo E. M., and Jacobs-Lorena, Marcelo (2001). Targeting 
Plasmodium ligands on mosquito salivary glands and midgut with a phage display 
peptide library, PNAS, 98(23):13278–13281. 
Gilbert, W. and Dressler, D. (1968). DNA Replication: The Rolling Circle Model, Cold Spring 
Harbor Symposia on Quantitative Biology, 33: 473-484. 
Gonzalez-Ceron, L., Santillan, F., Rodriguez, M.H., Mendez, D., and Hernandez-Avila, J.E. 
(2003). Bacteria in Midguts of Field-Collected Anopheles albimanus Block Plasmodium 
vivax Sporogonic Development. Journal of Medical Entomology, 40(3):371-374.  
Haines, L.R., Thomas, J.M., Jackson, A.M., Eyford, B.A., Razavi, M., Watson, C.N., Gowen, B., 
Hancock, R.E.W., and Pearson, T.W. (2009). Killing of Trypanosomatid Parasites by a 
Modified Bovine Host Defense Peptide, BMAP-18. Neglected Tropical Diseases, 3(2):1-
13. 
Hanahan, D. (1983). Studies on transformation of Escherichia coli with plasmids. Journal of 
Molecular Biology 166 (4): 557–580. 
Hemingway, J. and Ranson, H. (2000).  Insecticide Resistance in Insect Vectors of Human 
Disease.  Annual Review of Entomology 45:371-391. 
Hill, D.F., Short, N.J., Perham, R.N., and Petersen, G.B. (1991). DNA Sequence of Filamentous 
Bacteriophage Pf1. Journal of Molecular Biology, 281, 349-364. 
Hudson, J.A., Billington, C., Carey-Smith, G., and Greening, G. (2005). Bacteriophages as 
Biocontrol Agents in Food. Journal of Food Protection, 68(2): 426-437. 
Iannolo, G., Minenkova, O., Petruzzeli, R., and Cesareni, G. (1995). Modifying Filamentous 
Phage Capsid: Limits in the Size of the Major Capsid Protein. Journal of Molecular 
Biology, 248, 835-844. 
 
Ito, J. Ghosh, A., Moreira, L.A., Wimmer, E.A., and Jacobs-Lorena, M. (2002) Transgenic 
anopheline mosquitoes impaired in transmission of a malaria parasite. Nature, 417, 452-
455. 
 
James, A. (2011) Genetics-Based Field Studeis Prioritize Safety. Science, 331, 398. 
 
Kim, Y.J., Lebreton, F., Kaiser, C., Cruciere, C., and Remond, M. (2004). Expression of a Foot-
and-mouth disease virus immunodominant epitope by a filamentous bacteriophage 
vector. Archives of Virology, 149, 365-377. 
 
      68 
 
 Lanzillotti, R. and Coetzer, T.L. (2007) Phage display: a useful tool for malaria research? 
TRENDS in Parasitology, 24:3, 18-23. 
 
Olins, P.O., Devine, C.S., Rangwala, S.H., and Kavka, K.S. (1988) The T7 phage gene 10 leader 
RNA, a ribosome-binding stie that dramatically enhances the expression of foreign genes 
in Escherichia coli. Gene, 73(1):227-235. 
 
Paschke, M. (2006). Phage display systems and their applications. Applied Micobiology and 
Biotechnology, 70: 2-11. 
 
Pierce, J.C., and Masker, W. (1989). Genetic deletions between directly repeated sequences in 
bacteriophage T7.  Molecular Genetics and Genomics, 217: 215-222. 
 
Rakonjac, J., Bennett, N.J., Spagnuolo, J., Gagic, D., and Russel, M. (2011) Filamentous 
Bacteriophage: Biology, Phage Display, and Nanotechnology Applications. Current 
Issues in Molecular Biology, 13: 51-76. 
 
Riehle, M. A., Jacobs-Lorena, M. (2005) Using bacteria to express and display anti-parasite 
molecules in mosquitoes: current and future strategies. Insect Biochemistry and 
Molecular Biology 35: 699-707. 
 
Russel, M., Linderoth, N.A., and Sali, A. (1997) Filamentous phage assembly: variation on a 
protein export theme. Gene, 192, 23-32. 
 
Secretariat of the Convention on Biological Diversity (2000) Cartagena Protocol on Biosafety to 
the Convention on Biological Diversity: text and annexes. Montreal, Canada. 
 
Shine, J. and Dalgarno, L. (1975). Determinant of cistron specificity in bacterial ribosomes. 
Nature, 254: 34-38. 
 
Sidhu, S.S. (2001). Engineering M13 for phage display. Biomolecular Engineering, 18(2)57-63. 
 
Smith, G.P. (1985) Filamentous Fusion Phage: Novel Expression Vectors that Display Cloned 
Antigens on the Virion Surface. Science, 228, 1315-1317. 
 
Smith, G.P. and Petrenko, V.A. (1997). Phage Display. Chemistry Review, 97, 391-410. 
 
Straif, S.C., Mbogo, C.N.M., Toure, A.M., Walker, E.D., Kaufman, M., Toure, Y.T., and Beier, 
J.C. (1998). Midgut Bacteria in Anopheles gambiae and An. Funestus (Diptera: 
Culicidae) from Kenya and Mali. Journal of Medical Entomology, 35(3) 222-226. 
 
Subbaraman, N. (2011) Science snipes at Oxitec transgenic mosquito trial. Nature 
Biotechnology, 29, 9-11. 
 
      69 
 
       70 
 
Wang, K.C., Wang, X., Zhong, P., and Luo, P.P. (2010) Adapter-Directed Display: A Modular 
Design for Shuttling Display on Phage Surfaces. Journal of Molecular Biology, 395, 
1088-1101. 
